Annika Michelle van Smaalen

Ms. Annika Michelle van Smaalen

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Journal of Applied Physiology
Verified
Journal Article
Closed access
CWCalvin Jay de Wijs
Calvin Jay de Wijs
ASAnnika Michelle van Smaalen
Annika Michelle van Smaalen
LSLucia Streng
Lucia Streng
RSRobert Jan Stolker
Robert Jan Stolker
EMEgbert G. Mik
Egbert G. Mik
FHFloor A. Harms
Floor A. Harms
This study measured in vivo mitochondrial oxygen tension (mitoPo 2 ) and consumption (mitoV̇o 2 ). mitoPo 2 remained constant across ages, this stability of mitoPO 2 suggests consistent mitochondrial oxygen availability, eliminating the need for age-based adjustments in ongoing research using a low mitoPO 2 threshold to predict adverse events such as cardiac surgery associated acute kidney injury. However, mitoV̇o 2 significantly decreased with age, showing that age must be taken into account when interpreting mitoV̇o 2 values and when defining reference ranges.

13 December 2025 in Sensors
Verified
Journal Article
Open access
PDF file
ASAnnika Michelle van Smaalen
Annika Michelle van Smaalen
CWCalvin Jay de Wijs
Calvin Jay de Wijs
SHSanne Elisabeth Hoeks
Sanne Elisabeth Hoeks
EMEgbert G. Mik
Egbert G. Mik
FHFloor A. Harms
Floor A. Harms
Deep Sedation (DS) allows for shorter recovery times, reduced complication rates and increased cost-effectiveness compared to general anesthesia. In prolonged DS, High Flow Nasal Oxygen Therapy (HFNOT) ensures adequate oxygenation. Concerns remain regarding potential masking of inadequate ventilation and induction of hyperoxia. In this single-center observational study, we continuously monitored tcPCO2 and mitoPO2 in 30 patients using the SenTec Monitoring System and Cellular Oxygen METabolism (COMET®, Photonics Healthcare, Utrecht, The Netherlands) device to observe the effect of prolonged DS with HFNOT on periprocedural ventilation and oxygenation. Measurements were taken at baseline and 30, 60, 90 and 120 min after starting DS. tcPCO2 significantly increased after 30 (55.5 (34.5–61.9) mmHg, p < 0.001), 60 (54.8 (52.5–62.2) mmHg, p < 0.001), 90 (56.5 (53.1–69.3), p < 0.001) and 120 (55.8 (50.7–56.6) mmHg, p = 0.02) minutes of DS compared to baseline (37.3 (34.5–45.5) mmHg), surpassing the normal range (35–45 mmHg). mitoPO2 increased non-significantly from baseline (69.6 (43.9–76.7) mmHg) compared to 30 (80.5 (65.7–98.9) mmHg, p = 0.19), 60 (78.6 (70.3–85.8) mmHg, p = 0.19), 90 (74.4 (52.7–86.3) mmHg, p = 0.38) and 120 (85.6 (82.5–98.0) mmHg, p = 0.38) minutes. We observed increased tcPCO2 and a non-significant rise in mitoPO2 over time, without adverse effects. These findings highlight the potential of continuous sensor-based monitoring to improve real-time detection of ventilation and oxygenation.